SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (391)2/9/2002 12:37:27 AM
From: richardred   of 724
 
13-D is what I'm looking for, but I'm not expecting to see one in this case-Most would be acquiring companies would buy till just under 5% so they won't have to file a 13-D. Than Boom, the tender offer. TCW Asset Management Company-is the one thats added the most shares. Its assets are weighted in the bio area-11% of their portfolio. What NBSC needs, is a little boost in the next reported earnings to get a little more fund recognition. Comparisons should be favorable without the DGI drag. Quest Diagnostics is buying a testing lab. Hopefully they will need some new NBSC equipment to go along with it.

RR
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext